Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Yu-Ri Choi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Seoul St. Mary's Hospital, Seoul, Korea. Hauptthemen laut MEDLINE: Hypotension, Acetaminophen, Hematologic Neoplasms, Fever. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Purpose
Owing to their rapid antipyretic effects and predictable pharmacokinetic properties, acetaminophen (AAP) are commonly administered intravenously to severely ill patients. However, the potential development of hypotension as a consequence of intravenous AAP administration has not been thoroughly addressed. In this study, we aimed to identify the risk factors associated with the occurrence of serious hypotension following intravenous AAP administration during fever in patients with hematologic malignancies.
Methods
This retrospective study included hospitalized patients in the hemato‐oncology department. Patients were evaluated for serious adverse drug reactions (ADRs) resulting from intravenous administration of AAP between January and December 2023 at a tertiary hospital. The control group comprised patients who received intravenous AAP but did not experience hypotension. After univariable analysis, multivariable analysis was performed to identify the risk factors for serious hypotension.
Results
The serious hypotension group included 37 patients, while the control group had 111 patients randomized in a 1:3 ratio based on age and sex. Three risk factors were identified as increasing the likelihood of serious hypotension: body temperature prior to administration, acute kidney injury, and bacteremia. The mean arterial pressure prior to administration decreased the risk of developing serious hypotension by 0.96 times with an increase of 1 mmHg. There were no significant differences in the length of hospitalization or 90‐day mortality between the two groups.
Conclusions
Given that patients with hematologic malignancies and associated risk factors may develop serious hypotension that can lead to death, it is essential to closely monitor blood pressure during intravenous administration of AAP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Seoul St. Mary's Hospital, Seoul, Korea.
- College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do, Korea.
ORCID-Profile: Jee-Eun Chung
Förderung
- National Research Foundation of Korea
Zitieren
APA
Choi, Y. R., Park, J. I., An, S. S., Choi, J. H., Min, M. N., Kang, J. S., & Chung, J. E. (2025). Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70210
Vancouver
Choi YR, Park JI, An SS, Choi JH, Min MN, Kang JS, et al. Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70210
BibTeX
@article{Choi2025,
author = {Choi, Yu-Ri and Park, Ji-In and An, Seong-Sim and Choi, Ji-Hye and Min, Mi-Na and Kang, Jin-Suk and Chung, Jee-Eun},
title = {Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70210}
}
EUVIMED